Sheridan, the Physician Services division of AmSurg Corp. (NASDAQ: AMSG), is expanding its radiology services business through the acquisition of Radisphere, a group of over 100 radiologists who read more than one million studies per year.

Dr. Frank Seidelmann, co-founder and Chairman of Radisphere, commented, “Radisphere has built its reputation on a foundation of quality, service and technological innovation. We are excited about our partnership with Sheridan and its vision for developing a national radiology group practice.”

Radisphere is a leading national radiology group focused on hospital-based service delivery. It provides services in 25 states, which significantly expands Sheridan’s overall market position. The combined radiology services provider will read more than three million studies per year.

Christopher A. Holden, President and Chief Executive Officer of AmSurg, commented, “Radisphere’s geographic footprint complements Sheridan’s existing service areas and will allow us to strengthen our network of relationships with key hospitals. We will continue to evaluate and execute on great opportunities like Radisphere that provide both strategic value and growth for AmSurg.”

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the federal securities laws, including statements that are based on current expectations, forecasts and assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially. Forward-looking statements relate to expectations, beliefs, projections, future plans and strategies, anticipated events or trends and similar expressions concerning matters that are not historical facts.

In some cases, you can identify forward-looking statements by the use of forward-looking terminology such as “may,” “will,” “should,” “expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” or “predicts,” or the negative of these words or phrases or similar words or phrases, which are predictions of or indicate future events or trends and which do not relate solely to historical matters. While forward-looking statements reflect the Company’s good faith beliefs, assumptions and expectations, they are not guarantees of future performance. Furthermore, the Company disclaims any obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions or factors, new information, data or methods, future events or other changes. Certain risks and uncertainties related to the Company’s business are or will be described in greater detail in the Company’s filings with the SEC. The information set forth herein should be read in light of such risks.

About AmSurg and Sheridan

AmSurg Corp. operates an Ambulatory Services business that acquires, develops and operates ambulatory surgery centers in partnership with physician practice groups throughout the U.S. AmSurg also operates a Physician Services business, Sheridan, that provides outsourced physician services in multiple specialties to hospitals, ASCs and other healthcare facilities, primarily in the areas of anesthesiology, children’s services, emergency medicine and radiology. Through these businesses, as of September 30, 2014, AmSurg owned and operated 243 ASCs in 34 states and provides physician services in 25 states, employing more than 2,600 physicians and other healthcare professionals.

AmSurg Corp.Claire M. Gulmi, 615-665-1283Executive Vice President and Chief Financial Officer

Amsurg Corp. (NASDAQ:AMSG)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Amsurg Corp. Charts.
Amsurg Corp. (NASDAQ:AMSG)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Amsurg Corp. Charts.